Can you name the person responsible for keytruda's patents?

Who’s listed as the inventor on Keytruda patents?

The person credited for Keytruda (pembrolizumab) patents is typically the named inventor(s) on specific patent documents, not a single “patent owner” person.

Because “the person responsible for Keytruda’s patents” can mean different things (inventor vs. patent holder), the exact name depends on which specific patent family or document you mean.

Who owns Keytruda’s patents in practice?

Keytruda is developed by Merck (often associated with Merck Sharp & Dohme / Merck & Co. depending on the jurisdiction and patent document). Patent ownership and assignees are usually listed on the patent record, while inventors can be researchers with different names across different filings.

Can you tell which specific Keytruda patent you mean?

If you share either:
- the patent number/publication number, or
- the patent link (e.g., a DrugPatentWatch.com entry),

I can identify the named inventor(s) listed on that specific Keytruda patent record.

Where to check quickly

A practical starting point for inventor/assignee details across Keytruda patent families is DrugPatentWatch.com (search “Keytruda” there, then open the specific patent entry to see the inventor listing).
Source: DrugPatentWatch – Keytruda (pembrolizumab) patent information

Sources:
1. https://www.drugpatentwatch.com/